References
- Arbit E. The physiological rationale for oral insulin administration. Diabetes Technol Ther 2014;6:510–517.
- Elsayed A, Al Remawi M, Qinna N, et al. Formulation and characterization of an oily-based system for oral delivery of insulin. Eur J Pharm Biopharm 2009;73:269–279.
- Lee E, Lee J, Jon S. A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan. Bioconjug Chem 2010;21:1720–1723.
- Mundargi RC, Rangaswamy V, Aminabhavi TM. pH-Sensitive oral insulin delivery systems using Eudragit microspheres. Drug Dev Ind Pharm 2011;37:977–985.
- Niu M, Lu Y, Hovgaard L, et al. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. Eur J Pharm Biopharm 2012;81:265–272.
- Fonte P, Araújo F, Silva C, et al. Polymer-based nanoparticles for oral insulin delivery: revisited approaches. Biotechnol Adv 2015;33:1342–1354.
- Koning GA, Eggermont AM, Lindner LH, ten Hagen TL. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res 2010;27:1750–1754.
- Kowapradit J, Apirakaramwong A, Ngawhirunpat T, et al. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery. Eur J Pharm Sci 2012;47:359–366.
- Safinya CR, Ewert KK, Majzoub RN, Leal C. Cationic liposome-nucleic acid complexes for gene delivery and gene silencing. New J Chem 2014;38:5164–5172.
- Zhang X, Qi J, Lu Y, et al. Biotinylated liposomes as potential carriers for the oral delivery of insulin. Nanomedicine 2014;10:167–176.
- Mohanraj VJ, Barnes TJ, Prestidge CA. Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins. Int J Pharm 2010;392:285–293.
- Ma Z, Lim TM, Lim LY. Pharmacological activity of peroral chitosan–insulin nanoparticles in diabetic rats. Int J Pharm 2005;293:271–280.
- Sadeghi AMM, Dorkoosh FA, Avadi MR, et al. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods. Int J Pharm 2008;355:299–306.
- Varshosaz J, Minayian M, Ahmadi M, Ghassami E. Enhancement of solubility and antidiabetic effects of Repaglinide using spray drying technique in STZ-induced diabetic rats. Pharm Dev Technol 2016. [Epub ahead of print]. doi: 10.3109/10837450.2016.1143001.
- Elsayed A, Al-Remawi M, Maghrabi I, et al. Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system. Int J Pharm 2014;461:448–458.
- DeFelippis M, Dobbins M, Frank B, et al. US Patent. Publication number (US6034054), publication date Mar 7, 2000.
- Baynes BM, Wang DI, Trout BL. Role of arginine in the stabilization of proteins against aggregation. Biochemistry 2005;44:4919–4925.
- Al-Remawi M, Maghrabi I, Elsayed A, et al. Oral delivery of insulin using a lipoamino acid nanocarrier system. Pharmazie 2014;69:669–675.
- Reslan M, Demir YK, Trout BL, et al. Lack of a synergistic effect of arginine–glutamic acid on the physical stability of spray-dried bovine serum albumin. Pharm Dev Technol 2016. [Epub ahead of print]. doi: 10.1080/10837450.2016.1185116.
- Badwan A, Al-Remawi M, El-Taher T, Elsayed A. International Patent. Publication number (WO2007068311), publication date Jun 21, 2007.
- Elsayed A, Al-Remawi M, Farouk A, Badwan A. Insulin–chitosan polyelectrolyte nanocomplexes: preparation, characterization and stabilization of insulin. Sudan JMS 2010;5:99–110.
- Cheng Y, Luo X, Betz J, et al. In situ quantitative visualization and characterization of chitosan electrodeposition with paired sidewall electrodes. Soft Matter 2010;6:3177–3183.
- Cloninger C, Felton M, Paul B, et al. Control of pH during plasmid preparation by alkaline lysis of Escherichia coli. Anal Biochem 2008;378:224–225.
- Ye S, Wang C, Liu X, et al. New loading process and release properties of insulin from polysaccharide microcapsules fabricated through layer-by-layer assembly. J Control Release 2006;112:79–87.
- Al-Kurdi ZI, Chowdhry BZ, Leharne SA, et al. Low molecular weight chitosan–insulin polyelectrolyte complex: characterization and stability studies. Mar Drugs 2015;13:1765–1784.
- Ma Z, Yeoh HH, Lim LY. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J Pharm Sci 2002;91:1396–1404.
- Zhang L, Chan JM, Gu FX, et al. Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2008;2:1696–1702.
- Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001;47:3–19.
- Kisel MA, Kulik L, Tsybovsky IS, et al. Liposomes with phosphatidyl-ethanol as a carrier for oral delivery of insulin: studies in the rat. Int J Pharm 2001;216:105–114.
- Vanic Z. Phospholipid vesicles for enhanced drug delivery in dermatology. J Drug Discov Dev Deliv 2015;2:1–9.
- Arien A, Dupuy B. Encapsulation of calcitonin in liposome's depends on the vesicle preparation method. J Microencapsul 1997;14:753–760.
- Yoshie M, Masayuki N, Tsuneji N. Surface potential of liposomes with entrapped insulin. Int J Pharm 1990;64:89–98.
- Weingarten C, Moufti A, Delattre J, et al. Protection of insulin from enzymatic degradation by its association to liposomes. Int J Pharm 1985;26:251–257.
- Wiessner JH, Hwang KJ. Binding of insulin to the external surface of liposomes. Effect of surface curvature, temperature, and lipid composition. Biochim Biophys Acta 1982;689:490–498.
- Sun L, Zhang X, Wu Z, et al. Oral glucose- and pH-sensitive nanocarriers for simulating insulin release in vivo. Polym Chem 2014;5:1999–2009.
- Kachooei E, Moosavi-Movahedi A, Khodagholi F, et al. Oligomeric forms of insulin amyloid aggregation disrupt outgrowth and complexity of neuron-like pc12 cells. PLoS One 2012;7:e41344.
- Al-Sou’od K, Abu-Falahaa R, Al-Remawib M. Surface activity of some low molecular weight chitosan derivatives. Jordan J Chem 2013;8:1–17.
- Manosroi A, Khositsuntiwong N, Komno C, et al. Chemical stability and cytotoxicity of human insulin loaded in cationic DPPC/CTA/DDAB liposomes. J Biomed Nanotechnol 2011;7:308–316.
- Park SJ, Choi SG, Davaa E, Park JS. Encapsulation enhancement and stabilization of insulin in cationic liposomes. Int J Pharm 2011;415:267–272.
- Chia-Ming C, Weiner N. Gastrointestinal uptake of liposomes. I. In vitro and in situ studies. Int J Pharm 1987;37:75–85.
- Frohlich E, Roblegg E. Models for oral uptake of nanoparticles in consumer products. Toxicology 2012;291:10–17.
- Qinna N, Badwan A. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Des Dev Ther 2015;9:2515–2525.
- Radahmadi M, Shadan F, Karimian SM, Nasimi A. Effects of stress on exacerbation of diabetes mellitus, serum glucose and cortisol levels and body weight in rats. Pathophysiology 2006;13:51–55.